Succeeding in the Management of Heart Failure: The Evolving Role of the Family Practitioner

Release date: May 14, 2019
Expiration date: May 14, 2020
Estimated time to complete activity: 1.0 hour(s)



Keith C. Ferdinand, MD
Professor of Medicine
Department of Medicine
Gerald S. Berenson Endowed Chair in Preventive Cardiology
Tulane University School of Medicine
New Orleans, Louisiana


Javed Butler, MD, MPH, MBA
Professor and Chair of Medicine
Department of Medicine
University of Mississippi Medical Center
Jackson, Mississippi


Heart Failure (HF) continues to increase in both prevalence and incidence, and as the population continues to age, it is expected that the prevalence of this disease will continue to rise. Most patients with HF will present in a family practice setting; therefore, the community management of HF has become increasingly important, and the role of family practice providers even more crucial. Improving the reliability of diagnosis in primary care is essential to improving symptoms, quality of life, and disease prognosis. Furthermore, an early and correct diagnosis is needed when there may be no symptoms since treatment can delay or reverse disease progression.

Primary care physicians are in a pivotal position to make decisions regarding appropriate further investigation, treatment and referral, and to continue to provide education and support to patients during the post-discharge period. This activity will provide family practice providers with practical strategies to more effectively diagnose and manage patients with HF, as well as to employ motivational interviewing techniques and shared decision-making to ensure patients are informed regarding their condition and fully able to contribute to decision-making about future treatment options.


This educational initiative has been designed for family physicians involved in the prevention, diagnosis, and post-discharge management of patients with HF.


Upon completion of this educational activity, participants should be able to:

  • Describe primary care clinicians’ role in the monitoring, follow-up, and post-hospital discharge management of patients with HF
  • Identify key components for the diagnosis of HF
  • Individualize HF treatment based on patients’ clinical presentation and in alignment with the latest evidence-based guideline recommendations for management
  • Employ motivational interviewing to encourage patients to take an active role in disease management

There are no fees for participating and receiving CME credit for this activity. During the period of May 14, 2019 through May 14, 2020, participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pretest
  • Study the educational activity
  • Complete the posttest and the evaluation form

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better.




Integrity Continuing Education, Inc. is accredited with commendation by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians.


Integrity Continuing Education, Inc. designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.


For information about ACCME accreditation of this activity, please contact Integrity Continuing Education at (855) 835-4004 or


Integrity Continuing Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The following faculty/planners reported the financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:

Keith C. Ferdinand, MD
Consulting Fees: Boehringer Ingelheim, Inc., Lilly USA, Novartis Pharmaceuticals Corporation, Quantum Genomics, Janssen Scientific Affairs, LLC.

Javed Butler, MD, MPH, MBA
Consulting Fees: Amgen, Array BioPharma, AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Inc., Boehringer Ingelheim, Inc., Bristol-Myers Squibb, CVRx, G3 Pharmacuticals, Innolife Co., LTD., Janssen Scientific Affairs, LLC., Luitpold Pharmaceuticals, Inc., Medtronic, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Relypsa, Inc., Stealth Peptides, Inc., scPharmaceuticals, Vifor Pharma, ZS Pharma, Inc.

Rachel Brown, PharmD, MPH, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.


This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education and Novartis Pharmaceuticals Corporation do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


When you participate in an online educational activity sponsored by Integrity Continuing Education, Inc., you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and…(continued)


Windows 98, 2000, XP, 2003, Vista, and 7
Internet Explorer 6/7
Firefox 2
Mozilla 1.7 or higher
Netscape 8.1 or higher
Flash Player 10

Mac OS X 10.3, 10.4
Safari 1.3 (Mac OS 10.3)
Safari 2.0 or higher (Mac OS 10.4)
Firefox 2
Flash Player 10

Use of Internet Explorer browser is not recommended.

Click here for more information on minimum system requirements.


The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.


Provided by Integrity Continuing Education, Inc.


Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Continue to Pretest